COMMUNIQUÉS West-GlobeNewswire

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06/07/2026
Adds potential first-in-class, N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis oncology pipeline with [...]
REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
06/07/2026
Lausanne, Switzerland and Copenhagen, Denmark, July 06, 2026 (GLOBE NEWSWIRE) -- REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION RPN-002 is an orally administered [...]
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
06/07/2026
Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of action Combines oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad [...]
InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China
06/07/2026
BEIJING, July 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
04/07/2026
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases [...]
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
03/07/2026
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in [...]
Transactions of Managers and Closely Associated Persons
03/07/2026
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 [...]
Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations
03/07/2026
MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“ Premier Health” or the “Company” ) announces that, in connection with the proceedings initiated on June 23, 2026 by the Royal [...]
HorseBoost Gummies Officially Debut Featuring the Trendy Horse Gelatin Salt Trick Recipe for Male Enhancement
03/07/2026
Muira Puama, Maca, Ashwagandha, and L-Arginine Combine in a Male Vitality Gummy Formula Explained for Adult Men Largo, FL, July 03, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug [...]
Mark Leeds, D.O. PA Launches FloridaTaper.com, a Free Educational Resource on Benzodiazepine Tapering, Withdrawal, and BIND
04/07/2026
The new website from Mark Leeds, D.O. PA offers more than 60 physician-written articles, with new articles published daily, for patients, families, and clinicians navigating slow benzodiazepine dose reductions. Fort [...]
Burntide Gummies 2026 Update Highlights Ingredient Panel, Supplement Facts and Customer Service Support Details
03/07/2026
Apple Cider Vinegar, BHB Salts, and the Supplement Facts Panel Behind Burntide Gummies' Manufacturing Standards, Explained Largo, FL, July 03, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
HEALBE's Technology Powers SHARP's First Health-Focused Smartwatch
03/07/2026
SHARP Corporation integrates HEALBE's patented FLOW® technology into the Karada Mate Watch, enabling automatic calorie intake and hydration estimation Redwood City, CA, July 03, 2026 (GLOBE NEWSWIRE) -- SHARP [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 26- 2026
03/07/2026
Aggregated presentation by day and by market Purchases of own shares from June 22nd to June 26th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
Delta Clinics Reports Increase in Demand for Body Contouring Treatments
03/07/2026
Delta Clinics notes evolving patient preferences toward comprehensive body contouring procedures, often combining multiple treatments for more balanced results. The clinic attributes this shift to changing aesthetic [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2026
03/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 juin au 26 juin 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2026
SAN DIEGO, July 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
COSCIENS Biopharma Inc. Completes Share Capital Amendment
03/07/2026
TORONTO, ONTARIO, July 03, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”), today announced the previously announced consolidation (the “ Consolidation ”) of [...]
Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
03/07/2026
ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 Orion will publish Half-Year Report for January–June 2026 on Friday, 17 [...]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/07/2026
MONTREAL and CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]

Pages